Published in J Natl Cancer Inst on February 05, 1997
Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA (2006) 4.34
PancPRO: risk assessment for individuals with a family history of pancreatic cancer. J Clin Oncol (2007) 2.45
BayesMendel: an R environment for Mendelian risk prediction. Stat Appl Genet Mol Biol (2004) 2.34
The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews. Am J Hum Genet (1999) 2.03
Referral for cancer genetics consultation: a review and compilation of risk assessment criteria. J Med Genet (2004) 1.96
Risk factor modification and projections of absolute breast cancer risk. J Natl Cancer Inst (2011) 1.94
Validity of models for predicting BRCA1 and BRCA2 mutations. Ann Intern Med (2007) 1.94
Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine. CA Cancer J Clin (2011) 1.90
Cancer family history characterization in an unselected cohort of 121 patients with uveal melanoma. Fam Cancer (2010) 1.68
Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer. Mayo Clin Proc (2010) 1.51
A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families. Br J Cancer (2001) 1.44
Outcomes of multimodality breast screening for women at increased risk of familial breast cancer. World J Surg (2010) 1.38
Genetic susceptibility to pancreatic cancer. Mol Carcinog (2012) 1.36
Rating the risk factors for breast cancer. Ann Surg (2003) 1.35
BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families. Breast Cancer Res (2005) 1.31
Impact of the Cancer Risk Intake System on patient-clinician discussions of tamoxifen, genetic counseling, and colonoscopy. J Gen Intern Med (2005) 1.22
Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer. J Med Genet (2006) 1.17
Performance of BRCA1/2 mutation prediction models in Asian Americans. J Clin Oncol (2008) 1.14
Use of an educational computer program before genetic counseling for breast cancer susceptibility: effects on duration and content of counseling sessions. Genet Med (2005) 1.13
Multiple diseases in carrier probability estimation: accounting for surviving all cancers other than breast and ovary in BRCAPRO. Stat Med (2008) 1.13
Estimating CDKN2A carrier probability and personalizing cancer risk assessments in hereditary melanoma using MelaPRO. Cancer Res (2010) 1.08
Incorporating medical interventions into carrier probability estimation for genetic counseling. BMC Med Genet (2007) 1.07
A PALB2 germline mutation associated with hereditary breast cancer in Italy. Fam Cancer (2009) 1.07
Risk models used to counsel women for breast and ovarian cancer: a guide for clinicians. Fam Cancer (2001) 1.05
Breast cancer in the personal genomics era. Curr Genomics (2010) 1.02
RASSF1A polymorphism A133S is associated with early onset breast cancer in BRCA1/2 mutation carriers. Cancer Res (2008) 1.01
Classification of Missense Mutations of Disease Genes. J Am Stat Assoc (2005) 0.99
Selecting a BRCA risk assessment model for use in a familial cancer clinic. BMC Med Genet (2008) 0.99
Founder populations and their uses for breast cancer genetics. Breast Cancer Res (2000) 0.99
Performance of prediction models for BRCA mutation carriage in three racial/ethnic groups: findings from the Northern California Breast Cancer Family Registry. Cancer Epidemiol Biomarkers Prev (2009) 0.99
Effect of misreported family history on Mendelian mutation prediction models. Biometrics (2006) 0.92
The contribution of breast cancer pathology to statistical models to predict mutation risk in BRCA carriers. Fam Cancer (2010) 0.90
Breast cancer risk assessment in 64,659 women at a single high-volume mammography clinic. Acad Radiol (2011) 0.87
Distribution of BRCA1 and BRCA2 Mutations in Asian Patients with Breast Cancer. J Breast Cancer (2013) 0.86
Twenty-five years of breast cancer risk models and their applications. J Natl Cancer Inst (2015) 0.86
Evolutionary dynamics of BRCA1 alterations in breast tumorigenesis. J Theor Biol (2010) 0.84
Interpreting trial results in light of conflicting evidence: a Bayesian analysis of adjuvant chemotherapy for non-small-cell lung cancer. J Clin Oncol (2009) 0.84
Accuracy of BRCA1/2 mutation prediction models for different ethnicities and genders: experience in a southern Chinese cohort. World J Surg (2012) 0.83
Subjective versus objective risk in genetic counseling for hereditary breast and/or ovarian cancers. J Exp Clin Cancer Res (2009) 0.83
A family history of breast cancer will not predict female early onset breast cancer in a population-based setting. BMC Cancer (2008) 0.83
Opinions of women with high inherited breast cancer risk about prophylactic mastectomy: an initial evaluation from a screening trial including magnetic resonance imaging and ductal lavage. Health Expect (2005) 0.82
Frailty Models for Familial Risk with Application to Breast Cancer. J Am Stat Assoc (2013) 0.82
A Review of the Clinical Implications of Breast Cancer Biology. Electron Physician (2016) 0.82
Self administered screening for hereditary cancers in conjunction with mammography and ultrasound. Fam Cancer (2013) 0.81
Why should primary care physicians know about breast cancer genetics? West J Med (2001) 0.79
Hereditary cancer risk assessment: essential tools for a better approach. Hered Cancer Clin Pract (2013) 0.78
Testing for hereditary breast and ovarian cancer in the southeastern United States. Ann Surg (2000) 0.78
Serum levels of IGF-I and BRCA penetrance: a case control study in breast cancer families. Fam Cancer (2011) 0.78
Overestimation of hereditary breast cancer risk. Ann Surg (1998) 0.78
The deletion of exons 3-5 of BRCA1 is the first founder rearrangement identified in breast and/or ovarian cancer Spanish families. Fam Cancer (2013) 0.77
Linkage of a pedigree drawing program and database to a program for determining BRCA mutation carrier probability. Fam Cancer (2005) 0.76
Discovery and replication of microRNAs for breast cancer risk using genome-wide profiling. Oncotarget (2016) 0.75
An Assessment of Family History Information Captured in an Electronic Health Record. AMIA Annu Symp Proc (2015) 0.75
Impact of Genetic Counseling and Testing on Altruistic Motivations to Test for BRCA1/2: a Longitudinal Study. J Genet Couns (2015) 0.75
Re: probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J Natl Cancer Inst (1997) 0.75
Estimate of the penetrance of BRCA mutation and the COS software for the assessment of BRCA mutation probability. Fam Cancer (2015) 0.75
Attitudes and compliance of clinical management after genetic testing for hereditary breast and ovarian cancer among high-risk Southern Chinese females with breast cancer history. Fam Cancer (2014) 0.75
The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis (1997) 9.39
Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia. Lancet (1998) 3.07
Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing. J Clin Oncol (2001) 3.06
Benefits and risks of screening mammography for women in their forties: a statistical appraisal. J Natl Cancer Inst (1998) 2.48
Effect of BRCA1 and BRCA2 on the association between breast cancer risk and family history. J Natl Cancer Inst (1998) 2.32
Primaquine prophylaxis against malaria in nonimmune Colombian soldiers: efficacy and toxicity. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1998) 2.28
Mechanism of toxin secretion by Vibrio cholerae investigated in strains harboring plasmids that encode heat-labile enterotoxins of Escherichia coli. Proc Natl Acad Sci U S A (1984) 2.10
Detection of mitochondrial DNA mutations in pancreatic cancer offers a "mass"-ive advantage over detection of nuclear DNA mutations. Cancer Res (2001) 1.96
1st International consensus guidelines for advanced breast cancer (ABC 1). Breast (2012) 1.96
Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer. Oncogene (2008) 1.88
Coordinated assembly of multisubunit proteins: oligomerization of bacterial enterotoxins in vivo and in vitro. Proc Natl Acad Sci U S A (1988) 1.68
Missense mutations in disease genes: a Bayesian approach to evaluate causality. Am J Hum Genet (1998) 1.62
High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. J Clin Oncol (1993) 1.61
Prevalence and predictors of depressive, anxiety and substance use disorders in HIV-infected and uninfected men: a longitudinal evaluation. Psychol Med (1997) 1.52
Ethical ramifications of alternative means of recruiting research participants from cancer registries. Cancer (1999) 1.50
Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families. J Med Genet (2002) 1.48
Tolerability of prophylactic Lariam regimens. Trop Med Parasitol (1993) 1.42
Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America. AIDS (2001) 1.40
Migration, ethnicity and environment: HIV risk factors for women on the sugar cane plantations of the Dominican Republic. AIDS (1998) 1.39
Analysis of serious non-AIDS events among HIV-infected adults at Latin American sites. HIV Med (2010) 1.38
Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis. Br J Cancer (2008) 1.38
Expression and detection of different biotype-associated cell-bound haemagglutinins of Vibrio cholerae O1. J Gen Microbiol (1989) 1.36
Evaluation of widely used models for predicting BRCA1 and BRCA2 mutations. J Med Genet (2004) 1.33
In vitro neurite extension by granule neurons is dependent upon astroglial-derived fibroblast growth factor. Dev Biol (1988) 1.32
Mithramycin selectively inhibits transcription of G-C containing DNA. Am J Med Sci (1987) 1.31
Phase 2 trial of WR6026, an orally administered 8-aminoquinoline, in the treatment of visceral leishmaniasis caused by Leishmania chagasi. Am J Trop Med Hyg (2001) 1.27
Performing cost-effectiveness analysis by integrating randomized trial data with a comprehensive decision model: application to treatment of acute ischemic stroke. J Clin Epidemiol (1999) 1.27
Transient transcriptional activation of the Vibrio cholerae El Tor virulence regulator toxT in response to culture conditions. Infect Immun (1999) 1.26
Dominican, Mexican, and Puerto Rican prostitutes: drug use and sexual behaviors. Hisp J Behav Sci (1997) 1.21
Functional antibody activity elicited by fractional doses of Haemophilus influenzae type b conjugate vaccine (polyribosylribitol phosphate-tetanus toxoid conjugate). Clin Diagn Lab Immunol (2001) 1.20
Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation. Transplantation (2001) 1.19
Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysis. Br J Cancer (2009) 1.19
Seroprevalence of and risk factors for HIV-1 infection among female commercial sex workers in South America. Sex Transm Infect (2006) 1.19
Structural elements of the Streptomyces oriC region and their interactions with the DnaA protein. Microbiology (1998) 1.17
Bacteremia by multidrug-resistant Capnocytophaga sputigena. J Clin Microbiol (1994) 1.17
The Stroke Prevention Policy Model: linking evidence and clinical decisions. Ann Intern Med (1997) 1.16
Involving family members in cancer care: focus group considerations of patients and oncological providers. Psychooncology (2000) 1.15
Interactions of Bacillus thuringiensis crystal proteins with the midgut epithelial cells of Spodoptera frugiperda (Lepidoptera: Noctuidae). J Invertebr Pathol (1996) 1.14
Transplantation of microcarrier-attached hepatocytes into 90% partially hepatectomized rats. Hepatology (1988) 1.11
Effect of topical steroids on the healing of corneal endothelium. Invest Ophthalmol (1974) 1.11
Predicting the cost of illness: a comparison of alternative models applied to stroke. Med Decis Making (1998) 1.10
First injection and current risk factors for HIV among new and long-term injection drug users. AIDS Care (2000) 1.09
Immunoactive chimeric ST-LT enterotoxins of Escherichia coli generated by in vitro gene fusion. FEBS Lett (1986) 1.09
Intramuscular variation of fiber types in the brachial biceps and the lateral vastus muscles of elderly men: how representative is a small biopsy sample? Anat Rec (1982) 1.08
The epidemiology of HIV-1 infection in Peru, 1986-1990. AIDS (1996) 1.08
Web-based tissue microarray image data analysis: initial validation testing through prostate cancer Gleason grading. Hum Pathol (2001) 1.07
Genetic counseling and testing for breast-ovarian cancer susceptibility: what do women want? J Clin Oncol (1998) 1.07
Prevalence of human retroviral infection in Quillabamba and Cuzco, Peru: a new endemic area for human T cell lymphotropic virus type 1. Am J Trop Med Hyg (1997) 1.07
Biophysical characterization of zinc ejection from HIV nucleocapsid protein by anti-HIV 2,2'-dithiobis[benzamides] and benzisothiazolones. J Med Chem (1996) 1.06
Randomized comparison of vinorelbine and melphalan in anthracycline-refractory advanced breast cancer. J Clin Oncol (1995) 1.05
Fetal prognosis in varix of the intrafetal umbilical vein. J Ultrasound Med (1998) 1.04
Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809. Eur J Cancer (2011) 1.04
Pseudocyst of the umbilical cord: prenatal sonographic appearance and clinical significance. Obstet Gynecol (1999) 1.03
Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2. J Clin Oncol (1999) 1.03
Aortic origin of the right pulmonary artery. Am J Cardiol (1972) 1.03
Purification, characterization, and role of nucleases and serine proteases in Streptomyces differentiation. Analogies with the biochemical processes described in late steps of eukaryotic apoptosis. J Biol Chem (1999) 1.03
Pegfilgrastim and daily granulocyte colony-stimulating factor: patterns of use and neutropenia-related outcomes in cancer patients in Spain--results of the LEARN Study. Eur J Cancer Care (Engl) (2008) 1.02
Chromosomal instability in Streptomyces glaucescens: mapping of streptomycin-sensitive mutants. J Gen Microbiol (1983) 1.00
Association between the acquired immunodeficiency syndrome and infection with Salmonella typhi or Salmonella paratyphi in an endemic typhoid area. Arch Intern Med (1991) 1.00
Primary preventive health care among injection drug users, other sustained drug users, and non-users. Subst Use Misuse (2001) 0.98
Mutated in colorectal cancer, a putative tumor suppressor for serrated colorectal cancer, selectively represses beta-catenin-dependent transcription. Oncogene (2008) 0.98
Ophthalmoplegic migraine: reversible enhancement and thickening of the cisternal segment of the oculomotor nerve on contrast-enhanced MR images. AJNR Am J Neuroradiol (1999) 0.98
Neuropsychological abnormalities among HIV-infected individuals in a community-based sample. Neuropsychology (1997) 0.98
Lack of effectiveness of CO2 cryotherapy for treatment of CIN. Int J Gynaecol Obstet (2004) 0.97
Isolation of Cry1Ab protein mutants of Bacillus thuringiensis by a highly efficient PCR site-directed mutagenesis system. FEMS Microbiol Lett (1996) 0.96
Management of a harem breeding colony of rhesus monkeys to reduce trauma-related morbidity and mortality. J Med Primatol (1985) 0.95
A review of simulation modelling approaches used for the spread of zoonotic influenza viruses in animal and human populations. Zoonoses Public Health (2012) 0.95
Network analysis of swine shipments in Ontario, Canada, to support disease spread modelling and risk-based disease management. Prev Vet Med (2013) 0.93
Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancer. Br J Cancer (2012) 0.93
Lymphangioma-like Kaposi's sarcoma: report of four cases and review. J Eur Acad Dermatol Venereol (2006) 0.93
Resources and estuarine health: perceptions of elected officials and recreational fishers. J Toxicol Environ Health A (1999) 0.93
Prevention of Haemophilus influenzae type b colonization by vaccination: correlation with serum anti-capsular IgG concentration. J Infect Dis (2000) 0.93
Epidemiological study of the prevalence of allergic reactions to Hymenoptera in a rural population in the Mediterranean area. Clin Exp Allergy (1999) 0.93
Reactive perivascular T-cell infiltrate predicts survival in primary central nervous system B-cell lymphomas. Br J Haematol (2007) 0.92
Suppression of gene amplification in human cell hybrids. Science (1992) 0.92
Knowledge and attitudes towards food safety among Canadian dairy producers. Prev Vet Med (2009) 0.92
Synthesis in Vibrio cholerae and secretion of hepatitis B virus antigens fused to Escherichia coli heat-labile enterotoxin subunit B. Gene (1991) 0.91
Emerging genetic diversity of HIV-1 in South America. AIDS (2000) 0.91
Paclitaxel efficacy and toxicity in older women with metastatic breast cancer: combined analysis of CALGB 9342 and 9840. Ann Oncol (2011) 0.90
Morgagni's hernia resolved by laparoscopic surgery. J Laparoendosc Adv Surg Tech A (1998) 0.90
Static contraction of the quadriceps muscle in man: cardiovascular control and responses to one-legged strength training. Acta Physiol Scand (1984) 0.90
High expression of insulin-like growth factor binding protein-2 messenger RNA in epithelial ovarian cancers produces elevated preoperative serum levels. Int J Gynecol Cancer (2006) 0.90
On the blood compatibility of end-point immobilized heparin. J Biomater Sci Polym Ed (2000) 0.90
A pediatric trauma center without a pediatric surgeon: a four-year outcome analysis. J Trauma (1992) 0.89
Assessing the benefits of testing for breast cancer susceptibility genes: a decision analysis. Breast Dis (1998) 0.89
Genetic testing for susceptibility to breast cancer: findings from women's focus groups. J Womens Health (1997) 0.89
Nutritional status and the IgE response against Ascaris lumbricoides in children from a tropical slum. Trans R Soc Trop Med Hyg (1996) 0.89
Induction of beta-galactosidase in Streptomyces violaceus. Can J Microbiol (1979) 0.88
Dust and airborne exposure to allergens derived from cockroach (Blattella germanica) in low-cost public housing in Strasbourg (France). J Allergy Clin Immunol (1997) 0.87
Electronic functionalization of the surface of organic semiconductors with self-assembled monolayers. Nat Mater (2007) 0.87
Japanese encephalitis vaccine: persistence of antibody up to 3 years after a three-dose primary series. J Infect Dis (1995) 0.87
Ventral herniorrhaphy aided by pneumoperitoneum. Arch Surg (1986) 0.86
Longitudinal analysis of immune function in the first 3 years of life in thymectomized neonates during cardiac surgery. Clin Exp Immunol (2008) 0.86
The human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein zinc ejection activity of disulfide benzamides and benzisothiazolones: correlation with anti-HIV and virucidal activities. Antimicrob Agents Chemother (1997) 0.86
Unexpected diminished innervation of epidermis and dermoepidermal junction in lichen amyloidosus. Br J Dermatol (2008) 0.86
Neurological characteristics of HIV-infected men and women seeking primary medical care. Eur J Neurol (1999) 0.86
The LPS localization might explain the lack of protection of LPS-specific antibodies in abortion-causing Chlamydia psittaci infections. Res Microbiol (1994) 0.86